New hope for Tough-to-Treat breast cancer: experimental drug trial shows promise
NCT ID NCT04072952
Summary
This clinical trial is testing a new drug called ARV-471, both by itself and combined with an existing drug (palbociclib), for people with a specific type of advanced breast cancer (ER+/HER2-). The main goals are to find safe doses and see if the treatment can shrink tumors or stop cancer growth in patients whose cancer has progressed despite prior hormone therapy and chemotherapy. The study involves about 217 adults whose cancer is no longer responding to standard curative options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Trial Site
Palo Alto, California, 94304, United States
-
Clinical Trial Site
San Francisco, California, 94158, United States
-
Clinical Trial Site
Santa Monica, California, 90404, United States
-
Clinical Trial Site
Norwalk, Connecticut, 06856, United States
-
Clinical Trial Site
Fort Myers, Florida, 33901, United States
-
Clinical Trial Site
Tampa, Florida, 33612, United States
-
Clinical Trial Site
Chicago, Illinois, 60637, United States
-
Clinical Trial Site
Boston, Massachusetts, 02114, United States
-
Clinical Trial Site
Boston, Massachusetts, 02215, United States
-
Clinical Trial Site
Ann Arbor, Michigan, 48109, United States
-
Clinical Trial Site
St Louis, Missouri, 63110, United States
-
Clinical Trial Site
East Brunswick, New Jersey, 08816, United States
-
Clinical Trial Site
The Bronx, New York, 10461, United States
-
Clinical Trial Site
Charlotte, North Carolina, 28204, United States
-
Clinical Trial Site
Nashville, Tennessee, 37203, United States
-
Clinical Trial Site
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.